Roberto Rodriguez-Jimenez, MD, PhD

Health Research Institute Hospital 12 de Octubre (i+12 Institute), Madrid, Spain; Department of Psychiatry, Universidad Complutense de Madrid, Madrid, Spain; CIBERSAM-ISCIII (Biomedical Research Networking Centre for Mental Health), Spain; Department of Psychiatry, Hospital Universitario 12 de Octubre, Madrid, Spain

  • 4Articles
  • 9.7KReads1
  • 2008–2026Active
  • 48Collaborators
  • 22Citations2

1 Read counts for articles published before 2020 may include some non-human traffic.

2 Citation counts provided by Crossref.

About

Roberto Rodriguez-Jimenez, MD, PhD, is affiliated with the Health Research Institute Hospital 12 de Octubre, the Department of Psychiatry at Universidad Complutense de Madrid, and CIBERSAM-ISCIII in Spain. His publications from 2008 to 2026 cover clinical topics including addiction, child and adolescent psychiatry, psychotic disorders, schizophrenia and schizoaffective disorders, and suicide. His research has addressed factors influencing suicidal behavior in youth, neighborhood effects on first-episode psychosis, pharmacological adjuncts for negative symptoms of schizophrenia, and the relationship between cocaine use and alcohol dependence.

Publications

JCP
Factors Associated with Revisiting the Emergency Department due to Suicidal Behavior in Children and Adolescents
Original Research

Factors Associated with Revisiting the Emergency Department due to Suicidal Behavior in Children and Adolescents

January 28, 2026

Within 6 months of the initial emergency department (ED) visit, 21.7% of patients who initially attended the ED for self-injurious thoughts and behaviors returned for the same reason.
, , , et al
JCP
Neighborhood Vulnerability in First-Episode Psychosis
Original Research

Neighborhood Vulnerability in First-Episode Psychosis

March 13, 2023

Psychosocial difficulties in people with first-episode psychosis could be related to a lack of resources in the area where they live.
, , , et al
JCP
Original Research

Double-Blind, Placebo-Controlled Study of the Efficacy of Reboxetine and Citalopram as Adjuncts to Atypical Antipsychotics for Negative Symptoms of Schizophrenia

June 27, 2014

, , , et al
JCP
Original Research

Use of Cocaine by Heavy Drinkers Increases Vulnerability to Developing Alcohol Dependence: A 4-Year Follow-Up Study

March 18, 2008

, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Ketamine and Psychedelics

Listen to the Podcast
The Journal of Clinical Psychiatry podcast cover with Benjamin Brody, MD

Subscribe to read
more articles

Subscribe